These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1363741)

  • 1. [Arrhythmogenic effects of sultopride chlorhydrate: clinical and cellular electrophysiological correlation].
    Lande G; Drouin E; Gauthier C; Chevallier JC; Godin JF; Chiffoleau A; Le Marec H
    Ann Fr Anesth Reanim; 1992; 11(6):629-35. PubMed ID: 1363741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Torsades de pointes during sultopride poisoning].
    Montaz L; Varache N; Harry P; Aymes C; Turcant A; Delille F; Simonin D; Hass C
    J Toxicol Clin Exp; 1992 Dec; 12(8):481-6. PubMed ID: 1364061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulpiride induced torsade de pointes.
    Huang BH; Hsia CP; Chen CY
    Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the rabbit Purkinje fibre assay as an in vitro tool for assessing the risk of drug-induced torsades de pointes in humans.
    Aubert M; Osterwalder R; Wagner B; Parrilla I; Cavero I; Doessegger L; Ertel EA
    Drug Saf; 2006; 29(3):237-54. PubMed ID: 16524323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in effects of sultopride and sulpiride on dopamine turnover in rat brain.
    Moriuchi K; Imazu Y; Yoneda H
    Neurochem Res; 1995 Jan; 20(1):95-9. PubMed ID: 7739765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium.
    Davidenko JM; Cohen L; Goodrow R; Antzelevitch C
    Circulation; 1989 Mar; 79(3):674-86. PubMed ID: 2917391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning.
    Chang JH; Weng TI; Fang CC
    Am J Emerg Med; 2009 Oct; 27(8):1016.e1-3. PubMed ID: 19857426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes.
    Isbister GK; Murray L; John S; Hackett LP; Haider T; O'Mullane P; Gosselin S; Daly F
    Med J Aust; 2006 Apr; 184(7):354-6. PubMed ID: 16584372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsade de pointes associated with low-dose amisulpride: a case report.
    Chung AK; Chua SE
    J Psychopharmacol; 2010 Mar; 24(3):433-5. PubMed ID: 18957479
    [No Abstract]   [Full Text] [Related]  

  • 12. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents.
    Orth PM; Hesketh JC; Mak CK; Yang Y; Lin S; Beatch GN; Ezrin AM; Fedida D
    Cardiovasc Res; 2006 Jun; 70(3):486-96. PubMed ID: 16545351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM; Anderson IM
    Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of torsade de pointes from the QT interval: analysis of a case series of amisulpride overdoses.
    Joy JP; Coulter CV; Duffull SB; Isbister GK
    Clin Pharmacol Ther; 2011 Aug; 90(2):243-5. PubMed ID: 21716272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
    Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
    J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early afterdepolarization in a patient with complete atrioventricular block and torsades de pointes.
    Kurita T; Ohe T; Shimizu W; Hotta D; Shimomura K
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 1):33-8. PubMed ID: 7681173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
    Gintant GA; Limberis JT; McDermott JS; Wegner CD; Cox BF
    J Cardiovasc Pharmacol; 2001 May; 37(5):607-18. PubMed ID: 11336111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early afterdepolarizationlike activity in patients with class IA induced long QT syndrome and torsades de pointes.
    Kurita T; Ohe T; Shimizu W; Suyama K; Aihara N; Takaki H; Kamakura S; Shimomura K
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):695-705. PubMed ID: 9080496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsade de pointes associated with Astemizole overdose treated with magnesium sulfate.
    Hasan RA; Zureikat GY; Nolan BM
    Pediatr Emerg Care; 1993 Feb; 9(1):23-5. PubMed ID: 8488140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.